ClinicalTrials.Veeva

Menu

Efficacy and Safety of Etomidate Sedation in Gastric Endoscopic Submucosal Dissection

K

Korea University

Status

Completed

Conditions

Esophagogastroduodenoscopy
Sedation Complication
Endoscopic Submucosal Dissection

Treatments

Drug: Propofol Injection
Drug: Etomidate Injection

Study type

Interventional

Funder types

Other

Identifiers

NCT05407870
2020AN0375

Details and patient eligibility

About

During endoscopy, the patient is sedated to relieve pain and improve the ease of the procedure. Sedation endoscopy using propofol is effective, but has the disadvantage that cardiopulmonary side effects are frequently observed. However, etomidate is known to have hemodynamic and respiratory stability.The purpose of this study was to compare the efficacy and safety of etomidate and propofol in sedated gastric endoscopic submucosal dissection.

Enrollment

138 patients

Sex

All

Ages

19 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age 19-80
  • American Society of Anesthesiologists Physical Status Classification System (ASA) score of I, II, III
  • Scheduled endoscopy

Exclusion criteria

  • Pregnancy
  • Previous study History of hypersensitivity to drugs or substances containing soy or egg ingredients
  • Those who think that tracheal intubation will be difficult
  • Obstructive sleep apnea
  • History of side effects from previous sedatives
  • People with severe liver disease, kidney disease, or heart disease
  • Those who want a non-sleeping endoscope
  • A person who refuses to provide consent
  • SBP < 80mmHg or SpO2 < 90%
  • Patients with adrenocortical dysfunction, chronic steroid users

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

138 participants in 2 patient groups

Propofol
Active Comparator group
Description:
induction - 0.5mg/kg Propofol maintenance - 0.25mg/kg Propofol
Treatment:
Drug: Propofol Injection
Etomidate
Experimental group
Description:
induction - 0.25mg/kg Propofol + 0.05mg/kg Etomidate maintenance - 0.05mg/kg Etomidate
Treatment:
Drug: Etomidate Injection

Trial contacts and locations

1

Loading...

Central trial contact

Soo Jin Lee, MD; Han Jo Jeon, Ph.D

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems